{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:16:07Z","timestamp":1774566967365,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vascular endothelial growth factor (VEGF) increases vascular permeability and is important in pleural effusion formation. In studies using transforming growth factor \u03b2 (TGF- \u03b2 ) to produce pleurodesis, we observed that although TGF- \u03b2 was more effective than talc or doxycycline, it induced transient production of large pleural effusions. We hypothesized that TGF- \u03b2 stimulates VEGF production in pleural tissues in vivo, and by mesothelial cells in vitro. New Zealand White rabbits (n = 33) were given TGF- \u03b22 (1.7 or 5.0 \u03bc g), talc (400 mg\/kg), doxycycline (10 mg\/kg), or buffer intrapleurally. Pleural fluid was collected at 24 h. Intrapleural injection of TGF- \u03b22 induced a dose-dependent increase in VEGF production. The pleural fluid VEGF level was 2-fold higher in rabbits given 5.0 \u03bc g of TGF- \u03b22 than in those given 1.7 \u03bc g of TGF- \u03b22 and 3-fold higher than in those given buffer. VEGF levels were higher after the injection of TGF- \u03b22 than after administration of talc or doxycycline. The pleural fluid VEGF correlated significantly with the volume of pleural effusions (r = 0.79, p &amp;lt; 0.00001). In vitro, TGF- \u03b22 stimulated a dose-dependent increase in VEGF production from murine pleural mesothelial cells. At 4 and 24 h, TGF- \u03b22, but not talc or doxycycline, induced a significant increase in VEGF, when compared with controls. The mesothelial cell VEGF production was significantly reduced by anti-TGF- \u03b2 antibody in the TGF- \u03b22, talc, and control (buffer and medium) groups. In conclusion, mesothelial cells are an important source of VEGF. TGF- \u03b2 increases the VEGF production by mesothelial cells in vivo and in vitro.<\/jats:p>","DOI":"10.1164\/ajrccm.165.1.2104006","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:56:19Z","timestamp":1365087379000},"page":"88-94","source":"Crossref","is-referenced-by-count":76,"title":["Transforming Growth Factor \u03b2 Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells\n                    <i>in Vivo<\/i>\n                    and\n                    <i>in Vitro<\/i>"],"prefix":"10.1093","volume":"165","author":[{"given":"Y. C. Gary","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, St. Thomas Hospital and Vanderbilt University, Nashville, Tennessee; and Department of Medicine, University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee","family":"Melkerneker","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, St. Thomas Hospital and Vanderbilt University, Nashville, Tennessee; and Department of Medicine, University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, St. Thomas Hospital and Vanderbilt University, Nashville, Tennessee; and Department of Medicine, University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Light","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, St. Thomas Hospital and Vanderbilt University, Nashville, Tennessee; and Department of Medicine, University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk B.","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, St. Thomas Hospital and Vanderbilt University, Nashville, Tennessee; and Department of Medicine, University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,1,1]]},"reference":[{"key":"2026031623104686000_B1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1378\/chest.104.5.1486","article-title":"The incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia.","volume":"104","author":"Marel","year":"1993","journal-title":"Chest"},{"key":"2026031623104686000_B2"},{"key":"2026031623104686000_B3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s001099900019","article-title":"Molecular and biological properties of vascular endothelial growth factor.","volume":"77","author":"Ferrara","year":"1999","journal-title":"J Mol Med"},{"key":"2026031623104686000_B4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)64828-6","article-title":"Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor\/vascular permeability factor by human lung cancer cells.","volume":"157","author":"Yano","year":"2000","journal-title":"Am J Pathol"},{"key":"2026031623104686000_B5","first-page":"2912","article-title":"Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.","volume":"53","author":"Yeo","year":"1993","journal-title":"Cancer Res"},{"key":"2026031623104686000_B6","first-page":"957","article-title":"Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.","volume":"6","author":"Yano","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2026031623104686000_B7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thx.54.8.707","article-title":"Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions.","volume":"54","author":"Thickett","year":"1999","journal-title":"Thorax"},{"key":"2026031623104686000_B8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1378\/chest.116.3.760","article-title":"Vascular endothelial growth factor in pleural fluid.","volume":"116","author":"Cheng","year":"1999","journal-title":"Chest"},{"key":"2026031623104686000_B9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1164\/ajrccm.162.1.9909106","article-title":"A single intrapleural injection of transforming growth factor beta-2 produces an excellent pleurodesis in rabbits.","volume":"162","author":"Light","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623104686000_B10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/ajrccm.163.3.2002091","article-title":"Transforming growth factor-\u03b22 induces pleurodesis significantly faster than talc.","volume":"163","author":"Lee","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623104686000_B11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/thorax.55.12.1058","article-title":"Transforming growth factor beta-2 (TGF\u03b22) produces effective pleurodesis in sheep with no systemic complications.","volume":"55","author":"Lee","year":"2000","journal-title":"Thorax"},{"key":"2026031623104686000_B12","doi-asserted-by":"crossref","first-page":"L371","DOI":"10.1152\/ajplung.2000.279.2.L371","article-title":"Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells.","volume":"279","author":"Boussat","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026031623104686000_B13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3835(96)04161-4","article-title":"Vascular endothelial growth factor production is stimulated by gangliosides and TGF-\u03b2 isoforms in human glioma cells in vitro.","volume":"102","author":"Koochekpour","year":"1996","journal-title":"Cancer Let"},{"key":"2026031623104686000_B14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/BF02303745","article-title":"TGF beta-1 regulation of VEGF production by breast cancer cells.","volume":"4","author":"Donovan","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"2026031623104686000_B15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1378\/chest.118.6.1747","article-title":"Vascular endothelial growth factor level correlates with transforming growth factor beta isoform levels in pleural effusions.","volume":"118","author":"Cheng","year":"2000","journal-title":"Chest"},{"key":"2026031623104686000_B16","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.142.5.1536","article-title":"Monoclonal antibodies recognizing transforming growth factor-beta: bioactivity neutralization and transforming growth factor beta 2 affinity purification.","volume":"142","author":"Dasch","year":"1989","journal-title":"J Immunol"},{"key":"2026031623104686000_B17","first-page":"643","article-title":"Transforming growth factor beta-2 induced pleurodesis is not inhibited by corticosteroids.","volume":"56","author":"Lee","year":"2001","journal-title":"Thorax"},{"key":"2026031623104686000_B18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm\/139.1.199","article-title":"Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vitro.","volume":"139","author":"Antony","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026031623104686000_B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor and its receptors.","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"2026031623104686000_B20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/346371a0","article-title":"Suppression of experimental glomerulonephritis by antiserum against transforming growth factor \u03b21.","volume":"346","author":"Border","year":"1990","journal-title":"Nature"},{"key":"2026031623104686000_B21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","article-title":"Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.","volume":"97","author":"Murohara","year":"1998","journal-title":"Circulation"},{"key":"2026031623104686000_B22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7","article-title":"Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.","volume":"85","author":"Kraft","year":"1999","journal-title":"Cancer"},{"key":"2026031623104686000_B23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-2143(99)90116-6","article-title":"Growth factors VEGF and TGF-beta 1 in peritoneal dialysis.","volume":"134","author":"Zweers","year":"1999","journal-title":"J Lab Clin Med"},{"key":"2026031623104686000_B24","first-page":"184","article-title":"The pleura.","volume":"138","author":"Sahn","year":"1988","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623104686000_B25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02303785","article-title":"Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.","volume":"5","author":"Harmey","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"2026031623104686000_B26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/clin.1995.1076","article-title":"Interaction of murine peritoneal leukocytes and mesothelial cells: in vitro model system to survey cellular events on serosal membranes during inflammation.","volume":"75","author":"Muller","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"2026031623104686000_B27","first-page":"426","article-title":"Acute injury and regeneration of the mesothelium in response to asbestos fibers.","volume":"128","author":"Moalli","year":"1987","journal-title":"Am J Pathol"},{"key":"2026031623104686000_B28","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.160.10.5000","article-title":"Cellular mechanism of intraabdominal abscess formation by","volume":"160","author":"Gibson","year":"1998","journal-title":"Bacteroides fragilis. J Immunol"},{"key":"2026031623104686000_B29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1164\/ajrccm.161.2.9904123","article-title":"Talc induces apoptosis in human malignant mesothelial cells in vitro.","volume":"161","author":"Nasreen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623104686000_B30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4889(00)00040-9","article-title":"Mechanism of transforming growth factor-beta-1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells.","volume":"1497","author":"Chua","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"2026031623104686000_B31","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/S0021-9258(17)37365-9","article-title":"Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.","volume":"269","author":"Pertovaara","year":"1994","journal-title":"J Biol Chem"},{"key":"2026031623104686000_B32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor-beta in tissue fibrosis.","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"2026031623104686000_B33"},{"key":"2026031623104686000_B34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.1999.00775.x","article-title":"Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.","volume":"115","author":"Berse","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2026031623104686000_B35","first-page":"209","article-title":"Vascular endothelial growth factor: basic biology and clinical implications.","volume":"79","author":"Ferrara","year":"1997","journal-title":"EXS"},{"key":"2026031623104686000_B36","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1016\/S0021-9258(18)68561-8","article-title":"Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.","volume":"263","author":"Van Obberghen-Schilling","year":"1988","journal-title":"J Biol Chem"},{"key":"2026031623104686000_B37","first-page":"5508","article-title":"Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factor beta 1 and beta 2.","volume":"9","author":"Bascom","year":"1989","journal-title":"Mol Cell Biol"},{"key":"2026031623104686000_B38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.CIR.100.8.855","article-title":"Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming growth factor-beta 1 and platelet-derived growth factor AB.","volume":"100","author":"Kronemann","year":"1999","journal-title":"Circulation"},{"key":"2026031623104686000_B39","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/sj.onc.1201090","article-title":"Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia.","volume":"14","author":"Enholm","year":"1997","journal-title":"Oncogene"},{"key":"2026031623104686000_B40"},{"key":"2026031623104686000_B41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.5-suppl_1-45","article-title":"Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.","volume":"5","author":"Verheul","year":"2000","journal-title":"Oncologist"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/165\/1\/88\/67364205\/ajrccm_165_1_88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/165\/1\/88\/67364205\/ajrccm_165_1_88.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:12:47Z","timestamp":1773717167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/165\/1\/88\/8515815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,1,1]]},"published-print":{"date-parts":[[2002,1,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.165.1.2104006","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,1]]},"published":{"date-parts":[[2002,1,1]]}}}